12 That result is a useful reminder that not all GLP-1 mono-agonists are equal semaglutide is the strong end of that category, which makes tirzepatides and retatrutides numbers, achieved against a formidable GLP-1 benchmark, all the more notable
GLP-1 receptor agonists such as semaglutide carry the strongest clinical evidence for weight loss overall but work through a distinct mechanism and require separate evaluation
Research in the lab has shown that GIP promotes the growth of beta cells and may protect them by preventing apoptosis
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca 2+ signalling and insulin secretion due to blockade of L-type Ca 2+ channels in rat islet -cells
It has DHB, but also other things like bitter melon and l-baiba, which combine to help with weight loss and building muscle mass, he says